Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Change in Inventory (2023 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed Change in Inventory for 3 consecutive years, with $276000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Inventory rose 154.98% year-over-year to $276000.0, compared with a TTM value of $1.4 million through Sep 2025, up 1296.46%, and an annual FY2024 reading of -$579000.0, down 136.65% over the prior year.
  • Change in Inventory was $276000.0 for Q3 2025 at Fennec Pharmaceuticals, down from $797000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $797000.0 in Q2 2025 and bottomed at -$502000.0 in Q3 2024.
  • Average Change in Inventory over 3 years is $219818.2, with a median of $316000.0 recorded in 2023.
  • The sharpest move saw Change in Inventory crashed 258.86% in 2024, then soared 896.25% in 2025.
  • Year by year, Change in Inventory stood at $401000.0 in 2023, then tumbled by 116.21% to -$65000.0 in 2024, then soared by 524.62% to $276000.0 in 2025.
  • Business Quant data shows Change in Inventory for FENC at $276000.0 in Q3 2025, $797000.0 in Q2 2025, and $344000.0 in Q1 2025.